cancer clinical trials in chicago, IL
University of Chicago
Chicago, Illinois 60637 Mesothelioma
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chicago, Illinois 60674 Non Small Cell Lung Cancer
|
Rush University Medical Center
Trial Locations Rush University Medical Center John H. Stroger, Jr. Hospital of Cook County Hematology & Oncology Associates of Illinois Multiple Myeloma
|
Illinois Masonic Medical Center
Trial Locations Illinois Masonic Medical Center Swedish Covenant Hospital Hematology and Oncology Associates Saint Joseph Hospital Mount Sinai Hospital Medical Center University of Chicago Comprehensive Cancer Center Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
University of Chicago Comprehensive Cancer Center
Trial Locations University of Chicago Comprehensive Cancer Center University of Illinois Jesse Brown Veterans Affairs Medical Center Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
University of Chicago
Chicago, Illinois 60637 Acute Myeloid Leukemia
|
University of Chicago
Chicago, Illinois 60637 Thyroid Cancer
|
Rush University Medical Center
Chicago, Illinois 60612-3824 Non Small Cell Lung Cancer
|
University of Chicago
Chicago, Illinois 60637 Advanced Cancer
|
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois 60611 Gastric Cancer, Unspecified Adult Solid Tumor, Protocol Specific
|
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois 60611 Esophageal Cancer
|
Rush University Medical Center
Trial Locations Rush University Medical Center Northwestern University School of Medicine Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
|
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois 60611 Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
|
Childrens Memorial Hospital
Trial Locations Childrens Memorial Hospital University of Illinois Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
|
Rush University Medical Center
Trial Locations Rush University Medical Center University of Chicago Comprehensive Cancer Center Recurrent Endometrial Carcinoma
|
The University of Chicago Medical Center
Chicago, Illinois 60637-1470 Multiple Myeloma
|
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois 60611 Colorectal Cancer
|
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois 60611 Hereditary Clear Cell Renal Cell Carcinoma, Kidney Cancer
|
Rush University Medical Center
Trial Locations Rush University Medical Center University of Chicago Comprehensive Cancer Center Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
University of Chicago Medical Center
Chicago, Illinois 60637 Primary Progressive Multiple Sclerosis
|
University of Chicago Comprehensive Cancer Center
Trial Locations University of Chicago Comprehensive Cancer Center Childrens Memorial Hospital University of Illinois Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
Hematology and Oncology Associates
Trial Locations Hematology and Oncology Associates Northwestern University University of Chicago Comprehensive Cancer Center Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
University of Chicago
Chicago, Illinois 60637 Prostatic Neoplasms
|
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois 60614 Sickle Cell Disease
|
Northwestern University
Trial Locations Northwestern University University of Chicago Comprehensive Cancer Center Ovarian Stromal Cancer
|
Childrens Memorial
Chicago, Illinois 60614 Graft vs Host Disease, Graft-Versus-Host Disease
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chicago, Illinois 60674 Non-small Cell Lung Cancer
|
University of Illinois Cancer Center
Chicago, Illinois 60612-7243 Prostate Cancer
|
John H Stroger Jr Hospital of Cook County
Chicago, Illinois 60612-3785 Hand and Foot Syndrome
|
University of Chicago Medical Center
Chicago, Illinois 60637 Glioblastoma Multiforme
|
Rush University Medical Center
Chicago, Illinois 60612-3824 Melanoma
|
Cancer and Leukemia Group B
Chicago, Illinois 60606 HER2-positive Breast Cancer, Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
|
Rush University Medical Center
Chicago, Illinois 60612-3824 Lung Cancer, Non Small Cell Lung Cancer
|
University of Chicago Comprehensive Cancer Center
Trial Locations University of Chicago Comprehensive Cancer Center Childrens Memorial Hospital University of Illinois Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|